In acute coronavirus disease 19 (COVID‐19) patients, effective clinical risk stratification has
important implications on treatment and therapeutic resource distribution. This article …

Purpose To prospectively validate two risk scores to predict mortality (4C Mortality) and in-
hospital deterioration (4C Deterioration) among adults hospitalised with COVID-19. Methods …

The spectrum of disease severity and the insidiousness of clinical presentation make it
difficult to recognize patients with coronavirus disease 2019 (COVID-19) at higher risk of …

Background The SARS-CoV-2 pandemic led to a steep increase in hospital and intensive
care unit (ICU) admissions for acute respiratory failure worldwide. Early identification of …

Objectives To systematically evaluate the performance of COVID-19 prognostic models and
scores for mortality risk in older populations across three health-care settings: hospitals …

By September 2022, more than 600 million cases of SARS-CoV-2 infection have been
reported globally, resulting in over 6.5 million deaths. COVID-19 mortality risk estimators are …

Soluble suppression of tumorigenesis-2 (sST2) is an emerging biomarker for sepsis as well
as for heart failure. We investigated the prognostic utility of sST2 for predicting clinical …

Background: The COVID-19 standard of care (SOC) evolved rapidly during 2020 and 2021,
but its cumulative effect over time is unclear. Objective: To evaluate whether recovery and …

To test the prognostic performance of different scores, both specifically designed for patients
with COVID-19 and generic, in predicting in-hospital mortality and the need for mechanical …

Background The assessment of clinical prognosis of pregnant COVID-19 patients at hospital
presentation is challenging, due to physiological adaptations during pregnancy. Our aim …